Bisaryl (thio) morpholine derivatives as S1P modulators
CN102725272A
Synthesis of substituted pyrazoline carboxamidine derivatives
IL209974D0
Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1-carboxamidine derivatives
TW201127815A
Crystalline {(3s)-3-[({1-[(2r)-2-carboxy-4-(1-naphthyl)butyl]cyclopentyl}-carbonyl)amino]-2-oxo-2,3,4,5-tetrahydro-1h-1-benzazepin-1-yl}acetic acid, its preparation and use
TW201118090A
Monohydrate of pardoprunox
WO2011023796A1
Bifeprunox for treating addiction
SG178902A1
(thio)morpholine derivatives as s1p modulators
WO2011005098A1
Peptide ligands for targeting to the blood-brain barrier
WO2010070061A1
Compositions, kits and methods of a titration schedule for bifeprunox compounds
AU2009204851A1
Bifeprunox derivatives
US2007224180A1
Screening and treatment methods using IGS5 enzymes of the metalloprotease family
EP1966146A1
4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
EP1366044A1
8-{4-[3-(5-fluoro-1h-indol-3-yl)propyl ]-1-piperazinyl} -2-methyl-2h-1, 4-benzoxazin-3(4h)-one methanesulfonate with high affinity for the dopamine d2 receptor and the serotonin reuptake site
